节拍疗法：合理且对患者友好。 - Suppr

Suppr

超能文献

Metronomic therapy: it makes sense and is patient friendly.

作者信息

Kamen Barton A

出版信息

J Pediatr Hematol Oncol. 2005 Nov;27(11):571-2. doi: 10.1097/01.mph.0000192148.90120.15.

DOI:10.1097/01.mph.0000192148.90120.15

PMID:16282885

Abstract

摘要

相似文献

Metronomic therapy: it makes sense and is patient friendly.

J Pediatr Hematol Oncol. 2005 Nov;27(11):571-2. doi: 10.1097/01.mph.0000192148.90120.15.

A feasibility trial of antiangiogenic (metronomic) chemotherapy in pediatric patients with recurrent or progressive cancer.

J Pediatr Hematol Oncol. 2005 Nov;27(11):573-81. doi: 10.1097/01.mph.0000183863.10792.d4.

[A new treatment protocol targeting tumor vasculature--- metronomic chemotherapy combined radiotherapy].

Ai Zheng. 2007 Dec;26(12):1392-6.

Angiogenesis inhibitors in combinatorial approaches.

Angiogenesis. 2017 May;20(2):183-184. doi: 10.1007/s10456-017-9544-y. Epub 2017 Apr 5.

Targeted therapy: An elusive cancer target.

Nature. 2016 Sep 15;537(7620):S106-8. doi: 10.1038/537S106a.

Metronomic therapy: chemotherapy revisited.

Indian J Cancer. 2013 Apr-Jun;50(2):142-8. doi: 10.4103/0019-509X.117027.

Antiangiogenic strategies and agents in clinical trials.

Oncologist. 2000;5 Suppl 1:20-7. doi: 10.1634/theoncologist.5-suppl_1-20.

CANCER. Tumor angiogenesis, from foe to friend.

Science. 2015 Aug 14;349(6249):694-5. doi: 10.1126/science.aad0862.

Metronomic chemotherapy for cancer treatment: a decade of clinical studies.

Cancer Chemother Pharmacol. 2013 Jul;72(1):13-33. doi: 10.1007/s00280-013-2125-x. Epub 2013 Mar 9.

Anticancer therapy with angiogenesis inhibitors.

Tumori. 2001 Nov-Dec;87(6):S14-6.

引用本文的文献

The emerging low-dose therapy for advanced cancers.

Dose Response. 2009 Mar 24;7(3):208-20. doi: 10.2203/dose-response.08-010.Satti.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Metronomic therapy: it makes sense and is patient friendly.

J Pediatr Hematol Oncol. 2005 Nov;27(11):571-2. doi: 10.1097/01.mph.0000192148.90120.15.

A feasibility trial of antiangiogenic (metronomic) chemotherapy in pediatric patients with recurrent or progressive cancer.

J Pediatr Hematol Oncol. 2005 Nov;27(11):573-81. doi: 10.1097/01.mph.0000183863.10792.d4.

[A new treatment protocol targeting tumor vasculature--- metronomic chemotherapy combined radiotherapy].

Ai Zheng. 2007 Dec;26(12):1392-6.

Angiogenesis inhibitors in combinatorial approaches.

Angiogenesis. 2017 May;20(2):183-184. doi: 10.1007/s10456-017-9544-y. Epub 2017 Apr 5.

Targeted therapy: An elusive cancer target.

Nature. 2016 Sep 15;537(7620):S106-8. doi: 10.1038/537S106a.

Metronomic therapy: chemotherapy revisited.

Indian J Cancer. 2013 Apr-Jun;50(2):142-8. doi: 10.4103/0019-509X.117027.

Antiangiogenic strategies and agents in clinical trials.

Oncologist. 2000;5 Suppl 1:20-7. doi: 10.1634/theoncologist.5-suppl_1-20.

CANCER. Tumor angiogenesis, from foe to friend.

Science. 2015 Aug 14;349(6249):694-5. doi: 10.1126/science.aad0862.

Metronomic chemotherapy for cancer treatment: a decade of clinical studies.

Cancer Chemother Pharmacol. 2013 Jul;72(1):13-33. doi: 10.1007/s00280-013-2125-x. Epub 2013 Mar 9.

Anticancer therapy with angiogenesis inhibitors.

Tumori. 2001 Nov-Dec;87(6):S14-6.

引用本文的文献

The emerging low-dose therapy for advanced cancers.

Dose Response. 2009 Mar 24;7(3):208-20. doi: 10.2203/dose-response.08-010.Satti.